Literature DB >> 24004701

Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/Research Network (OKPRN) study.

Dewey C Scheid1, Robert M Hamm, Kalyanakrishnan Ramakrishnan, Laine H McCarthy, James W Mold.   

Abstract

PURPOSE: The purpose of this study was to describe colorectal cancer screening (CRCS) practices across a variety of primary care clinics and identify the methods used by primary care physicians (PCPs) with higher rates of CRCS ("exemplars").
METHODS: Physician questionnaires, structured interviews, medical record abstractions, and practice observations were conducted for 48 PCPs in 25 practices within a regional practice-based research network followed by secondary in-depth interviews to further investigate the practices of PCPs in the top quartile of CRCS rates ("exemplars").
RESULTS: We abstracted 3596 medical records (mean of 75 records per PCP). Overall, exemplars had higher CRCS rates (median, 57.2% vs. 27.6%; P < .001). Patients of exemplars had higher screening rates for fecal occult blood testing (FOBT) and colonoscopy but not for flexible sigmoidoscopy or double-contrast barium enemas. Exemplars adopted few of the system-based innovations proposed by researchers to improve CRCS. Colonoscopy was promoted as the preferred CRCS method. FOBT was recommended for patients who could not afford or did not want colonoscopy. Flexible sigmoidoscopy or barium enemas were rarely recommended. Exemplars used brief CRCS promotion scripts that informally paralleled theory-driven counseling techniques.
CONCLUSIONS: Experienced PCPs use brief CRCS promotion scripts including counseling techniques that improve CRCS performance. Future research should be directed toward whether these techniques can be used to create an intervention aimed at PCPs to improve CRCS.

Entities:  

Keywords:  Cancer Screening; Colorectal Cancer; Practice-based Research; Prevention; Primary Health Care

Mesh:

Substances:

Year:  2013        PMID: 24004701     DOI: 10.3122/jabfm.2013.05.120230

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  7 in total

1.  Team Science Approach to Developing Consensus on Research Good Practices for Practice-Based Research Networks: A Case Study.

Authors:  Kimberly Campbell-Voytal; Jeanette M Daly; Zsolt J Nagykaldi; Cheryl B Aspy; Rowena J Dolor; Lyle J Fagnan; Barcey T Levy; Hannah L Palac; LeAnn Michaels; V Beth Patterson; Miria Kano; Paul D Smith; Andrew L Sussman; Robert Williams; Pamela Sterling; Maeve O'Beirne; Anne Victoria Neale
Journal:  Clin Transl Sci       Date:  2015-11-25       Impact factor: 4.689

2.  Barriers to Colorectal Cancer Screening in a Primary Care Setting in Turkey.

Authors:  Mustafa Kursat Sahin; Servet Aker; Hatice Nilden Arslan
Journal:  J Community Health       Date:  2017-02

3.  System Strategies for Colorectal Cancer Screening at Federally Qualified Health Centers.

Authors:  Jeanette M Daly; Barcey T Levy; Carol A Moss; Camden P Bay
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

4.  Knowledge, attitude, and perceived barriers regarding colorectal cancer screening practices and risk factors among medical students in Saudi Arabia.

Authors:  Asma Althobaiti; Hoda Jradi
Journal:  BMC Med Educ       Date:  2019-11-14       Impact factor: 3.263

5.  Valuable Lessons for Pharmacist PBRNs: Insights and Experiences from Physician PBRN Members.

Authors:  Lourdes G Planas; Shane P Desselle; Kaitlyn Cao
Journal:  Pharmacy (Basel)       Date:  2019-08-27

6.  Colorectal Cancer Screening Prevalence and Adherence for the Cancer Prevention Project of Philadelphia (CAP3) Participants Who Self-Identify as Black.

Authors:  Elizabeth L Blackman; Camille Ragin; Resa M Jones
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

Review 7.  Screening for colorectal cancer: the role of the primary care physician.

Authors:  John K Triantafillidis; Constantine Vagianos; Aristofanis Gikas; Maria Korontzi; Apostolos Papalois
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.